Drug policy issues for health services research John White, PhD and Thomas Nicholson, PhD Western Kentucky University David F. Duncan Duncan and Associates.

Slides:



Advertisements
Similar presentations
M. Fe Caces, Ph.D. Statistician/Demographer Office of National Drug Control Policy Executive Office of the President Washington, DC Presentation for the.
Advertisements

2012 PATH Data Reporting Tison Thomas Substance Abuse and Mental Health Services Administration (SAMHSA) Rachael Kenney & Amy SooHoo SAMHSA Homeless and.
Uncompensated Care Maryland AAHAM December 19, 2014.
Do Primary Care Physicians Treating Minority Patients Report Greater Problems Delivering Quality Care? 1 A New Perspective on Racial and Ethnic Disparities.
Differences in Characteristics of Heroin Inhalers and Injectors at Admission to Treatment J. C. Maxwell, R. T. Spence, & T. M. Bohman UT Center for Social.
Foster Youth and the Transition to Adulthood: Findings from the Midwest Study Mark Courtney, Principal Investigator Amy Dworsky, Project Director.
Impact of Criminal Justice System Coercion on Drug Abuse Treatment David Duncan 1, John B. White 2, Thomas Nicholson 2 1 Duncan & Associates 2 Western.
1 The Importance of Successful Reentry to Jail Population Growth Presented by: Allen J. Beck, Chief Corrections Statistics Program Bureau of Justice Statistics.
Comparison of recreational marijuana users in three nations Monisha Jayakumar, MPH PhD Program in Maternal and Child Health Johns Hopkins Bloomberg School.
1 Arlene Ash QMC - Third Tuesday September 21, 2010 Analyzing Observational Data: Focus on Propensity Scores.
PPA 419 – Aging Services Administration Lecture 6a – Long- term Care and Medicaid.
Controlled Substance Prescribing Trends and Physician and Pharmacy Utilization Patterns: Epidemiological Analysis of the Maine Prescription Monitoring.
1 Reimbursing Health Care Providers It is all about striking the right balance between economic incentives for over-treatment and under- treatment Yaseen.
Health Care Financing and Managed Care. Objectives  To understand the basics of health care financing in the United States  To understand the basic.
Comparative Analysis of Marijuana Policy in the United States and the Netherlands: Questioning the Continuing Validity of the U.S. Approach.
Impact of Hospital Provider Payment Mechanism on Household Health Service Utilization in Vietnam (preliminary results) Sarah Bales Public Policy in Asia,
March Sliding Fee Scales, Patients Cap on Charges Eli Camhi, MSSW – Tom Hickey -
Washington State Hospital Association Washington state is one of the leaders in efficient use of services. Year-to-year differences in inpatient use patterns.
Overview Health Care Reform Impact: Incorporating the need to directly enroll clients in health insurance and monitor eligibility into a clinic setting.
CJ411-Chat 9 By: Amy Ng, ABD. Objectives Unit Reminders Decriminalization Harm reduction.
Using Research/Evaluation Questions to Define Data Collection and Findings: Findings from the FY 2004 KTOS Follow-up Study Robert Walker, Allison Mateyoke-Scrivener,
Suboxone as an Adjunctive Medication, Not Maintenance Dennis M. Donovan, Ph.D. UW Alcohol & Drug Abuse Institute Patricia C. Knox, Ph.D. Recovery Centers.
Mental Health and Substance Abuse Services Joe Vesowate Assistant Commissioner.
Soft Drugs in Amsterdam 英三 1 24 th Dec Summary Proponents of legalizing drugs should be legalized. They suggest that “soft” drugs, such as marijuana,
Healthcare Reform The “Affordable Care Act” How Will It Affect Substance Abuse Care?
I-502 Legalization of Marijuana in the State of Washington.
1 Jan Eldred Karen W. Linkins Lisa Mangiante December 10, 2008.
July 31, 2009Prepared by the Maine Health Information Center Overview of All Payer Claims Data Suanne Singer, Senior Consultant Maine Health Information.
New Jersey Department of Human Services Division of Addiction Services Substance Abuse Treatment Services Provider Performance Report Substance Abuse Treatment.
An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009.
Adolescent Outlook and Outcomes FY 2010 Maryland Alcohol and Drug Abuse Administration (ADAA) Thomas P. Cargiulo, Pharm. D., Director.
Farrokh Alemi, Ph.D., Mary Haack, Ph.D., Susie Nemes, Ph.D., Angela Harge, M.Ed., Heibatollah Baghi, Ph.D. This research was supported by a grant from.
Managed Care. In the broadest terms, Kongstvedt (1997) describes managed care as a system of healthcare delivery that tries to manage the cost of healthcare,
Coverage and Management of Medications for Treating Substance Abuse in Health Plans Constance M. Horgan, Sc.D. Sharon Reif, Ph.D. Dominic Hodgkin, Ph.D.
Introduction Results and Conclusions On demographic variables, analyses revealed that ATR clients were more likely to be Hispanic and employed, whereas.
SOURCE: Treatment Episode Data Set (TEDS) 2005SOURCE: Treatment Episode Data Set (TEDS) 2005 Admissions to Substance Abuse Treatment for the Abuse of Opioid.
CHAA Examination Preparation Encounter - Session III Pages University of Mississippi Medical Center.
Midwest Evaluation of the Adult Functioning of Former Foster Youth: Outcomes at Age 19 Chapin Hall Center for Children University of Chicago.
Health Reform: Local Safety Net Implications Karen J. Minyard, Ph.D., Executive Director, Georgia Health Policy Center, Georgia State University.
Substance Use among Older Adults (Age 50+): Current Prevalence and Future Expectations Presented by Joe Gfroerer U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES.
State-level Influences on Buprenorphine Utilization: Variations in Opioid Addiction Treatment Lisa M. Lines, MPH and Robin E. Clark, PhD University of.
"Immigrants & the Safety Net: Challenges from Health Care Reform” California Program on Access to Care Presented by: Monica Blanco-Etheridge Latino Coalition.
Legislative Update March 7, 2013 Road School. “Half Time” at the General Assembly.
DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration OFFICE OF APPLIED STUDIES Treatment Episode Data Set.
Health Reform: Is Your Community Ready for 2014? Frances M. Harding, Director SAMHSA’s Center for Substance Abuse Prevention 2011 School for Prevention.
Substance Abuse and Mental Health Services Administration Impact of Screening and Brief Intervention Grants in Seven States: Substance Use, Criminal Justice,
Supply and Cost of “Treat and Release” Visits to Hospital EDs Bernard Friedman PhD Pamela Owens PhD Agency for Healthcare Research and Quality.
Health Reform’s Cost Impact Can More be Done to Bend the Cost Curve?
Pediatric Asthma Hospitalizations: Impact of Managed Care in the Patterns of Outpatient Healthcare Utilization Capriles, JA., Rodríguez, MH., Rios, R.,
Trends in Access to Substance Abuse Treatment for Women and Men: Jeanne C. Marsh, PhD, Hee-Choon Shin, PhD, Dingcai Cao, PhD University of Chicago.
Healthcare Reform for Gender Specific Treatment in MA March 7, 2011.
Current Mental Health Care Systems
Current Mental Health Care Systems
Brian C. Martin, Ph.D., MBA East Tennessee State University
Proposition 64 County Behavioral Health Directors Association
Who pays for today’s healthcare?
US Census Data Ortman, Jennifer M., Victoria A. Velkoff, and Howard Hogan. An Aging Nation: The Older Population in the United States, Current Population.
Medication-Assisted Therapy at Coleman Profession Services
Current Mental Health Care Systems
Institute for Health Policy Studies
Drug-Control Laws The U.S. federal law known as the Controlled Substances Act will serve to illustrate a legal drug-classification system created to prevent.
1.03 Healthcare Finances.
Outpatient Alcohol/Drug Abuse Centers
Weaving a Strong Safety Net: Oral Health Care Access
Proposition 64 County Behavioral Health Directors Association
A QUESTION OF ACCESS.
Drugs Jan 2018.
Jim Messina, Ph.D., CCMHC, NCC, DCMHS-T
Vision Transformative collaboration that fosters resilient self-sustaining Recovery Communities. Mission To develop and sustain measurable solutions that.
The relationship between incarceration and opioid addiction treatment
Presentation transcript:

Drug policy issues for health services research John White, PhD and Thomas Nicholson, PhD Western Kentucky University David F. Duncan Duncan and Associates

Major Alternative Policy Schemes  Medicalization would allow currently illegal drugs to be prescribed by a physician for use by addicts (or perhaps even by recreational users);  Decriminalization would reduce the penalties for possession and use of illegal drugs to an offense (comparable to a traffic violation) rather than a felony or misdemeanor;

Schemes cont’d  Depenalization would eliminate all penalties for possession or use of illegal drugs but would retain penalties for production and trafficking in them;  Legalization would permit the currently illegal drugs to be sold and used like any other commodity, subject to such limits as the legislature might apply – for instance, age limits.  Any of these alternative approaches might be taken with any one or all of the currently illegal drugs.

Impact of Schemes  The current prohibition scheme has an important impact on the patient populations served by drug abuse treatment programs. The adoption of any of the alternative schemes would have major implications for the number of admissions, payer mix and case mix for treatment programs.

Data Source  To explore impact of these various schemes on drug treatment services we analyze data from the TEDS data set  We focus on referral patterns, payer mix, and other operational data.

Treatment Episode Data System  Is a continuation of the former Client Data System (CDS) that was originally developed by the Alcohol, Drug Abuse and Mental Health Services Administration  The TEDS data collection effort began in 1989 with three- year development grants to states.  Treatment providers that receive any state agency funding are expected to provide TEDS data for all clients admitted to treatment, regardless of the source of funding for individual clients.  SERIES/00056.xml

TEDS Data  20.5 million   Concatenated dataset  Covers all 50 States and Puerto Rico

Principal Source of Referral Including JusticeWithout Justice FrequencyPercentFrequencyPercent Individual6,972, ,972, Justice6,777, Care Provider2,410, ,410, Other Community Referral1,706, ,706, Other HC Provider1,442, ,442, Missing728, School260, , Employer/EAP250, , Total20,548, ,042,

Impact on Admissions  One-third of all treatment admissions are generated directly by the criminal justice system. If all of the currently illegal drugs were to be decriminalized, depenalized or legalized, then all or most of these criminal justice system referrals would cease.  Furthermore, it is likely that some substantial portion of the patients entering the system as self-referrals is actually motivated by a desire to avoid prosecution for a drug offense. The same is likely to be true of some referrals by healthcare providers or other community sources.  Thus, drug policy reform could reduce patient numbers by more than one-third.

Increased Admissions?  On the other hand, the prohibitionist approach of the current “war on drugs” stigmatizes drug users and abusers as criminals. This may be discouraging many persons in need of treatment from seeking it.  It is conceivable that taking a new approach might produce an increase in self-referral patients as large as or larger than the decrease in coerced patients.

Living Arrangements Including JusticeWithout Justice FrequencyPercentFrequencyPercent Independent Living9,859, ,153, Missing5,432, ,495, Dependent Living3,380, ,837, Homeless1,876, ,556, Total20,548, ,042,

Income Source Including JusticeWithout Justice FrequencyPercentFrequencyPercent Missing10,393, ,640, Wages/Salary3,708, ,900, Public Assistance1,380, ,109, Retirement/Pension505, , Other2,129, ,439, None2,432, ,593, Total20,548, ,042,

Impact on SES  Elimination of all criminal justice referrals would have very little effect on the distribution of either income sources or living arrangements in the patient care population. The greatest change would be an increase of roughly three percent in the proportion of patients who were homeless and of about two percent in the proportion who were receiving public assistance. These estimates are again hampered by a large amount of missing data on the variables.

Health Insurance Including JusticeWithout Justice FrequencyPercentFrequencyPercent Missing10,899, ,292, None6,139, ,374, Private1,342, , Medicaid1,321, ,018, Medicare/Other844, , Total20,548, ,042,

Payment Source Including JusticeWithout Justice FrequencyPercentFrequencyPercent Missing14,331, ,356, Self-pay1,937, ,002, Other Government1,497, , Medicaid823, , No Charge794, , Blue Cross/Blue Shield548, , Other545, , Medicare, Workman's Comp70, , Total20,548, ,042,

SES of Clients  Health Insurance coverage and Payment Source demonstrate the potential impact of a change in drug policy schemes on the payer mix for patients undergoing treatment for drug abuse. The large amount of missing data on these variables in the T.E.D.S. database limits our ability to draw any conclusions  Elimination of criminal justice referrals would result in an increase in the proportion of patients whose care is paid for by Medicaid and a decrease in the proportion of self payment and of payment by government programs other than Medicaid or Medicare.  Such shifts in source of payment for care would have major impacts on the administration of treatment services, including changes in the types and amounts of treatment provided.

Including JusticeWithout Justice FrequencyPercentFrequencyPercent Alcohol10,075, ,998, Cocaine/crack3,092, ,194, Heroin2,889, ,505, Marijuana/hashish2,454, ,088, Methamphetamine698, , Missing293, , Other opiates278, , None272, , Other amphetamine164, , Other83, , Benzodiazepines56, , PCP35, , Hallucinogens34, , Other sedatives27, , Inhalants22, , Non-prescription meds20, , Barbiturates16, , Other tranquilizer13, , Other stimulants12, , OTC7, , Total20,548, ,042, Case Mix

Case Mix Impacts  The case mix in terms of primary drug of abuse would be effected in a number of small but potentially important ways by drug policy reform.  If all criminal justice referrals were eliminated, then the proportion whose primary problem was heroin addiction would increase by five percent (from 14.1% to 19.2%)  Those reporting a primary problem with marijuana would decrease by more that three percent (from 11.9% to 8.3%).  Alcohol remains the primary substance abuse problem at admission.

Marijuana Impacts  Decriminalization, depenalization or legalization is most likely to come first for marijuana. Patients with a primary problem with marijuana constituted 2,454,902 patients during the period 1992 thru 2003, or about a quarter of a million per year.  Elimination of criminal justice referrals would mean that about 136,000 fewer patients would enter care for marijuana abuse annually.

Revenue Implications  Using costs estimates from the ADSS Cost Study the lowest cost per admission reported was for outpatient treatment without methadone ($1,433) *  This suggests an annual loss of $194,888,000 in revenue per year if marijuana initiatives are successful * Source:

Prior Admissions

First Time Admissions  Criminal justice referrals are more often persons who are entering treatment for the first time.  Eliminating criminal justice referrals would reduce the proportion of patients who were first time patients from 36.6% to 31.1% (3,213,316 fewer first time patients).

Impact of Scheme Changes  Drug policy reforms could be expected to result in a patient population that: Is smaller by one-third Includes a larger proportion of patients on Medicaid Includes a larger proportion of patients who are homeless or on welfare Includes a larger proportion of heroin addicts Includes a smaller proportion of marijuana abusers Includes a larger proportion of patients with a history of relapse  Such changes in patient population would present treatment agencies with greater clinical challenges than the current state of the system.